Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $4.25 in the prior trading day, Eledon Pharmaceuticals Inc (NASDAQ: ELDN) closed at $4.35, up 2.35%. In other words, the price has increased by $2.35 from its previous closing price. On the day, 1.92 million shares were traded. ELDN stock price reached its highest trading level at $4.52 during the session, while it also had its lowest trading level at $4.2.
Ratios:
Our goal is to gain a better understanding of ELDN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.12 and its Current Ratio is at 8.12. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On January 28, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELDN now has a Market Capitalization of 260485712 and an Enterprise Value of 209910832.
Stock Price History:
The Beta on a monthly basis for ELDN is 0.68, which has changed by -0.1792453 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, ELDN has reached a high of $5.54, while it has fallen to a 52-week low of $2.32. The 50-Day Moving Average of the stock is 53.20%, while the 200-Day Moving Average is calculated to be 32.58%.
Shares Statistics:
The stock has traded on average 1.14M shares per day over the past 3-months and 2322110 shares per day over the last 10 days, according to various share statistics. A total of 59.88M shares are outstanding, with a floating share count of 55.84M. Insiders hold about 6.75% of the company’s shares, while institutions hold 64.35% stake in the company. Shares short for ELDN as of 1760486400 were 3515385 with a Short Ratio of 3.07, compared to 1757894400 on 5429434. Therefore, it implies a Short% of Shares Outstanding of 3515385 and a Short% of Float of 6.5600000000000005.
Earnings Estimates
At present, 6.0 analysts are actively evaluating the performance of Eledon Pharmaceuticals Inc (ELDN) in the stock market.The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.17 and low estimates of -$0.33.
Analysts are recommending an EPS of between -$0.49 and -$1.26 for the fiscal current year, implying an average EPS of -$0.85. EPS for the following year is -$1.12, with 4.0 analysts recommending between -$0.97 and -$1.31.
